Physician profile
Andrea Damour
NPI 1740277730
$1,345.61
in general payments reported to CMS, 2019-2025
20 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $40.28 · 2021: $28.82 · 2022: $45.43 · 2023: $172 · 2024: $234 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $344.38 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $169.52 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $126.78 | 2024-2025 | Myfembree, Gemtesa |
| Organon LLC | $97.80 | 2022-2024 | Nexplanon |
| Therapeuticsmd, INC. | $90.52 | 2019 | |
| Exeltis, USA INC. | $70.99 | 2023-2024 | Slynd |
| Coopersurgical, INC. | $61.96 | 2019 | |
| Biogen, INC. | $55.40 | 2024-2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $48.79 | 2019 | |
| Allergan, INC. | $43.56 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.23 | 2019-2022 | |
| Roche Diagnostics Corporation | $35.85 | 2019 | |
| Steris Corporation | $28.82 | 2021 | |
| Avion Pharmaceuticals | $25.13 | 2019 | |
| Pfizer INC. | $23.34 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $20.66 | 2025 | |
| Merck Sharp & Dohme LLC | $18.00 | 2019 | |
| Boston Scientific Corporation | $14.70 | 2019 | |
| Covidien LP | $13.91 | 2019 | |
| Hologic Sales and Service, LLC | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Damour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.